IL6 and diabetes mellitus: As for the molecular mechanism of anti-diabetes, five compounds with better activity in vitro were selected to explore their effects on the AKT1, IL-6 and VEGFA mRNA expression, indicating that their anti-diabetes mechanism was related to PI3K-AKT signaling pathway.